Autori: Schadendorf Dirk
| Naslov | Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial (Meeting Abstract) |
| Autori | Schadendorf Dirk ... Kandolf-Sekulovic Lidija O ... Mijuskovic Zeljko P ... (broj koautora 20) |
| Info | ANNALS OF ONCOLOGY, (2024), vol. 35 br. , Suppl. 2, str. 1235-1236 |
| Projekat | F. Hoffmann-La Roche Ltd. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Length of treatment after partial or complete remission in immunotherapy for metastatic melanoma: An EUMelaReg real world study (Meeting Abstract) |
| Autori | Asher Nethanel Mohr Peter Ellebaek Eva Bender Marc Mangana Joanna Kandolf Lidija O Gavrilova Iva Ascierto Paolo Antonio Gogas Helen Rutkowski Piotr Schadendorf Dirk Bastholt Lars Weichenthal Michael |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2024), vol. 42 br. 16, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAF(V600)-positive melanoma: Interim analysis of the ImmunoCobiVem study. (Meeting Abstract) |
| Autori | Schadendorf Dirk ... Kandolf-Sekulovic Lidija O ... Mijuskovic Zeljko P ... (broj koautora 20) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2022), vol. 40 br. 16, Suppl. S, str. - |
| Projekat | F. Hoffmann-La Roche Ltd. |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
